Ledger.Open graph →
SEC Form D · Amendment · filed April 20, 2017

Velicept Therapeutics, Inc

Offering
$26.3M
Sold
$18.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MALVERN, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Paul Abelow · Morganville, NJDirectorJohn Shields · Wakefield, MAExec · DirectorDawn A. Cummings · Grand Cayman, Cayman IslandsDirectorJames Bennethum · Gaylord, MIDirectorSunil K. Gottipati · Princeton, NJDirectorDavid Hirsch · Greenwich, CTDirectorDouglas Gessl · Malvern, PAExecScott Morenstein · New York, NYDirectorStephen Tullman · Malvern, PADirectorI. R. Garr · Germantown, MDExecJohn Giordano · Wakefield, MADirectorTiffany Freitas · Wakefield, MADirectorAmir Haleem · San Francisco, CAExec · DirectorJames Walker · Malvern, PAExec · DirectorDave Blundin · Wakefield, MADirectorLikai C. Lin · Boston, MADirectorStanley R. Westreich · Germantown, MDExecGregory A. Ellis · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗